← all drugs
Flurazepam Hydrochloride Capsule
in shortage · Neurology · Snapshot: 2026-10-09
Day 1,528
of this shortage, counting from the FDA's first posting on 08/03/2022
- Manufacturers listed
- Rising Pharma Holdings, Inc., Chartwell Molecular Holdings LLC
- Reported reason(s)
- Regulatory delay
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | Rising Pharma Holdings, Inc. | Unavailable | 09/01/2026 |
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Chartwell Molecular Holdings LLC | Available | 09/15/2026 |
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Chartwell Molecular Holdings LLC | Available | 09/15/2026 |
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Chartwell Molecular Holdings LLC | Available | 09/15/2026 |
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Chartwell Molecular Holdings LLC | Available | 09/15/2026 |
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | Rising Pharma Holdings, Inc. | Unavailable | 09/01/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.